Chemical Biology & Drug Design · 2011 · 19 citations · 29 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryEnzymologyStructural BiologyEnzyme InhibitionLigand BindingMolecular DockingProtein-ligand DockingStructure-based Pharmacophore ModelingVirtual ScreeningActive Site AnalysisMolecular Docking Of InhibitorsPhosphatasesProtein-ligand Complex Modeling
Despite a series of persuasive experimental evidence for the involvement of eyes absent protein tyrosine phosphatases in various human cancers, no small-molecule inhibitor has been reported so far. We have identified seven novel inhibitors of eyes absent homologue 2 (Eya2) with IC(50) values ranging from 1 to 70 μm by the virtual screening with docking simulations and enzyme inhibition assay. Atomic charges of the active-site Mg(2+) ion complex are calculated to enhance the accuracy of docking simulations. The newly discovered inhibitors are structurally diverse and have various chelating groups for the Mg(2+) ion. The interactions with the amino acid residues responsible for the stabilizations of the inhibitors in the active site of Eya2 are addressed in detail.
29
An introduction to hydrogen bonding
Choice Reviews Online · 1998 · 6.3K citations
Natural Sciences, Chemistry, Physics +17